As a sequel to the Novel Coronavirus out break in China, the supply of actual pharmaceutical ingredients APIs has been severely affected and the Drug Controller of India DCI has directed the Food and Drug Administrations FDAs across the country to collect information of available stocks of 58 APIs, from drug manufacturers Source IT News Raju Vernekar
Read more / Original news source: http://e-pao.net/ge.asp?heading=5&src=120220